by Robert Minicucci | Apr 22, 2020 | biopharma, cancer, clinical data, clinical research, Clinical Trials, Coronavirus, COVID-19, EMR, Oncology, Pharma, Uncategorized
Oncology clinical trials have been disrupted as hospitals dedicate more resources to care for COVID-19 patients. While the scope delays and suspensions are hard to assess, halting these trials can create devastating effects for patients in need of experimental...
by Inteliquet | Feb 24, 2020 | cancer, Clinical Trials, healthcare, Oncology, patients
Scott Kratz recently joined the Global Leadership Panel of Fight Cancer Global (FCG). Scott joined FCG to be a resource and advise in the area of clinical trials and patient recruitment. Here is background on FCG: They are fighting cancer by working to transform the...
by Robert Minicucci | Dec 20, 2019 | ASH, cancer, clinical development strategy, clinical research, Clinical Trials, EMR, hematology, life sciences, Oncology, primary data, Uncategorized
The American Society of Hematology’s (ASH) 61st Annual Meeting & Exposition is the premier annual conference for malignant and non-malignant hematology. They work hard to bring new levels of collaboration and advocacy to find better treatments. Thank you to ASH...
by Robert Minicucci | Dec 16, 2019 | clinical research, CROs, FOCR, lung cancer, NSCLC, Oncology, patients, Pharma, RCTs, RWD/RWE, Uncategorized
What if real-world data (RWD) sources can increase the speed of getting therapies to market? Instead of waiting five years for a clinical trial to be designed, enrolled, and completed … what if we could do...
by Robert Minicucci | Oct 12, 2019 | Clinical Trials, disruptive technology, DPHARM, life sciences, Oncology, patient centric, patients, Pharma, Uncategorized
“Too much cost. Too much time. Too much uncertainty,” were themes heard over and over at 2019’s DPharm: Disruptive Innovations Conference in Boston. The two-day gathering highlights the promises and challenges of bringing innovation to drug development, so...
by Robert Minicucci | Aug 20, 2019 | biopharma, clinical development strategy, clinical research, Clinical Trials, disruptive technology, life sciences, Oncology, patient centric, Pharma, Uncategorized
Joy is Inteliquet’s Vice President of Life Sciences and Strategic Account Management. Her career began as an oncology nurse and then she moved to implementing multiple phase I-III investigational clinical trials of various biologics and chemotherapeutics, including...
